4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004521
Director sold 2,000 shares at an average $66.56 ($133,122)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HERSHBERG ROBERT · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-15 | Exercise or conversion : show line 1 in the form | +2,000 | $0.45 | $900 | 2,000 | D |
| 2021-01-15 | Sale : show line 2 in the form | −1,378 | $66.34 | $91,417 | 622 | D |
| 2021-01-15 | Sale : show line 3 in the form | −622 | $67.05 | $41,705 | 0 | D |
| Open-market sales · 2,000 sh · avg $66.56 · $133,122 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-15 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −2,000 | 57,000 | D |
Loading xslF345X03/doc4.xml…